Atlas Trials

Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients

Clinical trial NCT01911520 · COMPLETED

Trial details

NCT number
NCT01911520
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Morbidly Obese Patients
Start date
2011-01-01
Primary completion
2012-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.